DCP and AFP are widely used surveillance markers for HCC, although some HCC patients present with low DCP or AFP levels (25), and DCP can be affected by the administration of warfarin and vitamin K antagonists (26). This evidence concerns the gene ACE and hepatocellular carcinoma.